Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Annali Dell'Istituto Superiore Di Sanita|March 25, 2011
Innovative approaches to clinical development and trial designJohn J Orloff, Donald StanskiEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 2, 2007
Current issues relating to drug safety especially with regard to the use of biomarkers: a meeting report and progress updatePaul Rolan, Meindert Danhof, Donald Stanski, et al.Journal of Clinical Pharmacology|November 19, 2016
Exposure-Response Analyses Supporting Ticagrelor Dosing Recommendation in Patients With Prior Myocardial InfarctionDaniel Röshammar, Joakim Nyberg, Tomas Andersson, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 7, 2010
Understanding pharmacokinetics using realistic computational models of fluid dynamics: biosimulation of drug distribution within the CSF space for intrathecal drugsAndreas Kuttler, Thomas Dimke, Steven Kern, et al.Pharmaceutical Statistics|January 12, 2018
Integrating dose estimation into a decision-making framework for model-based drug developmentJames Dunyak, Patrick Mitchell, Bengt Hamrén, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 17, 2017
Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meetGabriel Helmlinger, Nidal Al-Huniti, Sergey Aksenov, et al.Journal of the American Society of Nephrology : JASN|December 25, 2003
Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factorNathalie M Fiaschi-Taesch, Soledad Santos, Vasumathi Reddy, et al.Obstetrics and Gynecology|April 12, 2003
Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosisMarjorie M Luckey, Nigel Gilchrist, Henry G Bone, et al.Nature Reviews. Drug Discovery|October 10, 2009
The future of drug development: advancing clinical trial designJohn Orloff, Frank Douglas, Jose Pinheiro, et al.The New England Journal of Medicine|September 20, 2007
Zoledronic acid and clinical fractures and mortality after hip fractureKenneth W Lyles, Cathleen S Colón-Emeric, Jay S Magaziner, et al.Pageof 2